XML 26 R16.htm IDEA: XBRL DOCUMENT
v3.7.0.1

10. SEGMENTS | 3 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2017 | Mar. 31, 2017
Segment Reporting [Abstract] |  |
SEGMENTS | We operate our businesses principally through two reportable segments: Aethlon, which represents our therapeutic business activities, and ESI, which represents our diagnostic business activities. Our reportable segments have been determined based on the nature of the potential products being developed. We record discrete financial information for ESI and our chief operating decision maker reviews ESI’s operating results in order to make decisions about resources to be allocated to the ESI segment and to assess its performance. Aethlon’s revenue is generated primarily from government contracts to date and ESI does not yet have any revenues. We have not included any allocation of corporate overhead to the ESI segment. The following tables set forth certain information regarding our segments:
|  | Three Months Ended June 30, |
|  | 2017 |  |  | 2016 |
Revenues: |  |  |  |  |  |
Aethlon |  | $ | – |  |  | $ | 4,635 |
ESI |  |  | – |  |  |  | – |
Total Revenues |  | $ | 392,073 |  |  | $ | 4,635 |
Operating Losses: |  |  |  |  |  |  |  |
Aethlon |  | $ | (1,141,406 | ) |  | $ | (1,092,990 | )
ESI |  |  | (18,843 | ) |  |  | (38,662 | )
Total Operating Loss |  | $ | (1,160,249 | ) |  | $ | (1,131,652 | )
Net Losses: |  |  |  |  |  |  |  |
Aethlon |  | $ | (1,826,708 | ) |  | $ | (2,097,887 | )
ESI |  |  | (18,843 | ) |  |  | (38,662 | )
Net Loss Before Non-Controlling Interests |  | $ | (1,845,551 | ) |  | $ | (2,136,549 | )
Cash: |  |  |  |  |  |  |  |
Aethlon |  | $ | 326,464 |  |  | $ | 1,291,537 |
ESI |  |  | 742 |  |  |  | 2,722 |
Total Cash |  | $ | 327,206 |  |  | $ | 1,294,259 |
Total Assets: |  |  |  |  |  |  |  |
Aethlon |  | $ | 492,324 |  |  | $ | 1,419,226 |
ESI |  |  | 16,827 |  |  |  | 41,806 |
Total Assets |  | $ | 509,151 |  |  | $ | 1,461,032 |
Capital Expenditures: |  |  |  |  |  |  |  |
Aethlon |  | $ | 23,705 |  |  | $ | 1,545 |
ESI |  |  | – |  |  |  | – |
Capital Expenditures |  | $ | 23,705 |  |  | $ | 1,545 |
Depreciation and Amortization: |  |  |  |  |  |  |  |
Aethlon |  | $ | 9,326 |  |  | $ | 5,323 |
ESI |  |  | – |  |  |  | 4,895 |
Total Depreciation and Amortization |  | $ | 9,326 |  |  | $ | 10,218 |
Interest Expense: |  |  |  |  |  |  |  |
Aethlon |  | $ | (188,604 | ) |  | $ | (42,167 | )
ESI |  |  | – |  |  |  | – |
Total Interest Expense |  | $ | (188,604 | ) |  | $ | (42,167 | )
| We operate our businesses principally through two reportable segments: Aethlon, which represents our therapeutic business activities, and ESI, which represents our diagnostic business activities. Our reportable segments have been determined based on the nature of the potential products being developed. We record discrete financial information for ESI and our chief operating decision maker reviews ESI’s operating results in order to make decisions about resources to be allocated to the ESI segment and to assess its performance. Aethlon’s revenue is generated primarily from government contracts to date and ESI does not yet have any revenues. We have not included any allocation of corporate overhead to the ESI segment. The following tables set forth certain information regarding our segments:
|  | Fiscal Years Ended March 31, |
|  | 2017 |  |  | 2016 |
Revenues: |  |  |  |  |  |
Aethlon |  | $ | 392,073 |  |  | $ | 886,572 |
ESI |  |  | – |  |  |  | – |
Total Revenues |  | $ | 392,073 |  |  | $ | 886,572 |
Operating Losses: |  |  |  |  |  |  |  |
Aethlon |  | $ | (5,945,293 | ) |  | $ | (3,953,402 | )
ESI |  |  | (153,064 | ) |  |  | (431,432 | )
Total Operating Loss |  | $ | (6,098,357 | ) |  | $ | (4,384,834 | )
Net Losses: |  |  |  |  |  |  |  |
Aethlon |  | $ | (7,153,662 | ) |  | $ | (4,527,184 | )
ESI |  |  | (153,064 | ) |  |  | (431,432 | )
Net Loss Before Non-Controlling Interests |  | $ | (7,306,726 | ) |  | $ | (4,958,616 | )
Cash: |  |  |  |  |  |  |  |
Aethlon |  | $ | 1,558,667 |  |  | $ | 2,114,285 |
ESI |  |  | 1,034 |  |  |  | 9,452 |
Total Cash |  | $ | 1,559,701 |  |  | $ | 2,123,737 |
Total Assets: |  |  |  |  |  |  |  |
Aethlon |  | $ | 1,698,249 |  |  | $ | 2,475,686 |
ESI |  |  | 28,119 |  |  |  | 53,430 |
Total Assets |  | $ | 1,726,368 |  |  | $ | 2,529,116 |
Capital Expenditures: |  |  |  |  |  |  |  |
Aethlon |  | $ | 16,433 |  |  | $ | 9,307 |
ESI |  |  | – |  |  |  | – |
Capital Expenditures |  | $ | 16,433 |  |  | $ | 9,307 |
Depreciation and Amortization: |  |  |  |  |  |  |  |
Aethlon |  | $ | 22,370 |  |  | $ | 18,943 |
ESI |  |  | 10,043 |  |  |  | 19,581 |
Total Depreciation and Amortization |  | $ | 32,413 |  |  | $ | 38,524 |
Interest Expense: |  |  |  |  |  |  |  |
Aethlon |  | $ | 304,330 |  |  | $ | 573,782 |
ESI |  |  | – |  |  |  | – |
Total Interest Expense |  | $ | 304,330 |  |  | $ | 573,782 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration